J. B. CHEMICALS & PHARMACEUTICALS LIMITED

Andere Sprachen J. B. Chemicals & Pharmaceuticals Limited

Aktien

A3EV5Z

INE572A01036

JBCHEPHARM

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:00:50 26.04.2024			% 5 Tage	% 1. Jan.
1 864 ^INR	+0,48 %		+4,81 %	+14,75 %

08.04.	J. B. Chemicals & Pharmaceuticals Limited ernennt Akshay Tanna zum nicht-exekutiven, nicht-unabhängigen Direktor	CI
09.03.	J. B. Chemicals & Pharmaceuticals Limited gibt das Ableben von Ranjit Shahani, Chairman und Non-Executive, Independent Director, bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as A Non-Executive, Non-Independent Director	08.04.
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Assessment Unit, Income Tax Department	22.03.
J. B. Chemicals & Pharmaceuticals Limited Announces Demise of Ranjit Shahani, Chairman and Non-Executive, Independent Director	09.03.
KKR Reportedly Considers Selling Controlling Stake in JB Pharma	28.02.
JB Chemicals' Consolidated Profit Climbs in Fiscal Q3; Shares Jump 4%	07.02.
J.B. Pharma Seeks Acquisitions	07.02.
J. B. Chemicals & Pharmaceuticals Appoints CFO	07.02.
JB Chemicals Names CFO	06.02.
Indian drugmaker J B Chemicals posts Q3 profit rise on strong demand	06.02.
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	06.02.
J. B. Chemicals & Pharmaceuticals Limited Appoints Narayan Saraf as the Chief Financial Officer, with Effect from February 23, 2024	06.02.
J. B. Chemicals & Pharmaceuticals Limited Declares Interim Dividend for Financial Year 2023-24	06.02.
J B Chemicals & Pharmaceuticals : Earnings Call Transcript – Entry into Ophthalmology segment	25.12.
J. B. Chemicals & Pharmaceuticals Limited Announces Execution of Trade Mark License Agreement with Novartis Innovative Therapies Ag and Promotion & Distribution Agreement with Novartis Healthcare Private Limited	19.12.
JB Pharma Seeks Acquisitions	24.11.
J.B. Chemicals Records Rise in Fiscal Q2 Consolidated Net Profit	08.11.
J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as an Additional Director	07.11.
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	07.11.
J.B. Chemicals' CFO Resigns	08.09.23
J. B. Chemicals & Pharmaceuticals Limited Announces Cessation of Lakshay Kataria, Chief Financial Officer and Key Managerial Personnel, Effective November 30, 2023	07.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen J. B. Chemicals & Pharmaceuticals Limited

Aktien

A3EV5Z

INE572A01036

JBCHEPHARM

Andere Sprachen

Filter